Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Johnson & Johnson (JNJ), Valeant Pharmaceuticals Intl Inc (VRX): Why The Cooper Companies, Inc. (COO) Earnings Could Look Healthier

Page 1 of 2

The Cooper Companies, Inc. (NYSE:COO) will release its quarterly report on Thursday, and with the stock trading at all-time highs, investors are looking for strong results from the company. Despite some headwinds that have hurt other medical-device makers, The Cooper Companies, Inc. (NYSE:COO) earnings appear likely to grow both this quarter and well into the future.

The Cooper Companies, Inc.

The Cooper Companies, Inc. (NYSE:COO) has focused on two major segments for its success. On one hand, it makes vision-care products, with an emphasis on contact lenses. Yet Cooper also makes products to supply medical professionals specializing in obstetrics and gynecology, with the goal of improving health care delivery to women. Let’s take an early look at what’s been happening with The Cooper Companies, Inc. (NYSE:COO) over the past quarter and what we’re likely to see in its report.

Stats on Cooper

Analyst EPS Estimate $1.72
Change From Year-Ago EPS 18.6%
Revenue Estimate $410.54 million
Change From Year-Ago Revenue 8.6%
Earnings Beats in Past 4 Quarters 3

Source: Yahoo! Finance.

How far can Cooper earnings climb?
Analysts have gotten more optimistic about the prospects for Cooper earnings in recent months, boosting their July quarter estimates by a nickel per share and their full fiscal-year projections by more than triple that amount. The stock has continued its strong move upward, rising 17% since late May.

The Cooper Companies, Inc. (NYSE:COO) carried its positive momentum from last quarter, reporting solid results from its fiscal second quarter. Earnings climbed 36% on an 11% jump in revenue, with CEO Bob Weiss specifically referring to the company’s newly launched MyDay single-use contact lenses as an example of its success in delivering on its long-term goals. The company managed to increase its margins in part by cutting royalty payments on its silicone hydrogel lens sales, and Cooper also reduced its outstanding debt by more than a fifth during the quarter.

Part of The Cooper Companies, Inc. (NYSE:COO)’s success has come from identifying and delivering on customers’ wants and needs. In vision, sales of one-day contact lenses carry much higher profit margins than its monthly lenses. That’s consistent with the experience of health care giant Johnson & Johnson (NYSE:JNJ), which also specifically noted daily lenses as a growth opportunity for its worldwide vision-care business. Cooper recently got an analyst upgrade that cited continued strength in contact lens sales in projecting a favorable outcome for shareholders.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!